Safety of Ixekizumab in Adult Patients with Moderate-to-Severe Psoriasis: Data from 17 Clinical Trials with Over 18,000 Patient-Years of Exposure
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2190-9172
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Safety of Ixekizumab in Adult Patients with Moderate-to-Severe Psoriasis: Data from 17 Clinical Trials with Over 18,000 Patient-Years of Exposure ; volume:12 ; number:6 ; day:27 ; month:5 ; year:2022 ; pages:1431-1446 ; date:6.2022
Dermatology and therapy ; 12, Heft 6 (27.5.2022), 1431-1446, 6.2022
- Creator
-
Griffiths, Christopher E. M.
Gooderham, Melinda
Colombel, Jean-Frederic
Terui, Tadashi
Accioly, Ana P.
Gallo, Gaia
Zhu, Danting
Blauvelt, Andrew
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s13555-022-00743-9
- URN
-
urn:nbn:de:101:1-2022081319033877300137
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:30 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Griffiths, Christopher E. M.
- Gooderham, Melinda
- Colombel, Jean-Frederic
- Terui, Tadashi
- Accioly, Ana P.
- Gallo, Gaia
- Zhu, Danting
- Blauvelt, Andrew
- SpringerLink (Online service)
Other Objects (12)
Treatment Persistence of Ixekizumab in Adults with Moderate-to-Severe Plaque Psoriasis Participating in the Canadian Patient Support Program
Safety and Efficacy of Ixekizumab in Chinese Adults with Moderate-to-Severe Plaque Psoriasis: A Prospective, Multicenter, Observational Study
A Comprehensive Review of Ixekizumab Efficacy in Nail Psoriasis from Clinical Trials for Moderate-to-Severe Psoriasis and Psoriatic Arthritis
Severe Generalized Pustular Psoriasis Successfully Treated with Ixekizumab: A Case Report
Ixekizumab and Ustekinumab Efficacy in Nail Psoriasis in Patients with Moderate-to-Severe Psoriasis: 52-Week Results from a Phase 3, Head-to-Head Study (IXORA-S)
Relationship Between Rapid Skin Clearance and Quality of Life Benefit: Post Hoc Analysis of Japanese Patients with Moderate-to-Severe Psoriasis Treated with Ixekizumab (UNCOVER-J)
Simultaneous Nail and Skin Clearance in Ixekizumab Head-to-Head Trials for Moderate-to-Severe Psoriasis and Psoriatic Arthritis
Ixekizumab for Treating Moderate-to-Severe Plaque Psoriasis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
Ixekizumab bei Psoriasis-Arthritis & axialer Spondyloarthritis : umfassende Daten zu Ixekizumab: schnelle und kontinuierliche Wirksamkeit
Ixekizumab: an alternative for HIV-positive psoriasis patients
Ixekizumab (Plaque Psoriasis) : Addendum zum Auftrag A17-07
Ixekizumab (Plaque Psoriasis) : Nutzenbewertung gemäß § 35a SGB V
Treatment Persistence of Ixekizumab in Adults with Moderate-to-Severe Plaque Psoriasis Participating in the Canadian Patient Support Program
Safety and Efficacy of Ixekizumab in Chinese Adults with Moderate-to-Severe Plaque Psoriasis: A Prospective, Multicenter, Observational Study
A Comprehensive Review of Ixekizumab Efficacy in Nail Psoriasis from Clinical Trials for Moderate-to-Severe Psoriasis and Psoriatic Arthritis
Severe Generalized Pustular Psoriasis Successfully Treated with Ixekizumab: A Case Report
Ixekizumab and Ustekinumab Efficacy in Nail Psoriasis in Patients with Moderate-to-Severe Psoriasis: 52-Week Results from a Phase 3, Head-to-Head Study (IXORA-S)
Relationship Between Rapid Skin Clearance and Quality of Life Benefit: Post Hoc Analysis of Japanese Patients with Moderate-to-Severe Psoriasis Treated with Ixekizumab (UNCOVER-J)
Simultaneous Nail and Skin Clearance in Ixekizumab Head-to-Head Trials for Moderate-to-Severe Psoriasis and Psoriatic Arthritis
Ixekizumab for Treating Moderate-to-Severe Plaque Psoriasis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
Ixekizumab bei Psoriasis-Arthritis & axialer Spondyloarthritis : umfassende Daten zu Ixekizumab: schnelle und kontinuierliche Wirksamkeit
Ixekizumab: an alternative for HIV-positive psoriasis patients
Ixekizumab (Plaque Psoriasis) : Addendum zum Auftrag A17-07
Ixekizumab (Plaque Psoriasis) : Nutzenbewertung gemäß § 35a SGB V
Treatment Persistence of Ixekizumab in Adults with Moderate-to-Severe Plaque Psoriasis Participating in the Canadian Patient Support Program
Safety and Efficacy of Ixekizumab in Chinese Adults with Moderate-to-Severe Plaque Psoriasis: A Prospective, Multicenter, Observational Study
A Comprehensive Review of Ixekizumab Efficacy in Nail Psoriasis from Clinical Trials for Moderate-to-Severe Psoriasis and Psoriatic Arthritis
Severe Generalized Pustular Psoriasis Successfully Treated with Ixekizumab: A Case Report
Ixekizumab and Ustekinumab Efficacy in Nail Psoriasis in Patients with Moderate-to-Severe Psoriasis: 52-Week Results from a Phase 3, Head-to-Head Study (IXORA-S)
Relationship Between Rapid Skin Clearance and Quality of Life Benefit: Post Hoc Analysis of Japanese Patients with Moderate-to-Severe Psoriasis Treated with Ixekizumab (UNCOVER-J)
Simultaneous Nail and Skin Clearance in Ixekizumab Head-to-Head Trials for Moderate-to-Severe Psoriasis and Psoriatic Arthritis
Ixekizumab for Treating Moderate-to-Severe Plaque Psoriasis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
Ixekizumab bei Psoriasis-Arthritis & axialer Spondyloarthritis : umfassende Daten zu Ixekizumab: schnelle und kontinuierliche Wirksamkeit
Ixekizumab: an alternative for HIV-positive psoriasis patients
Ixekizumab (Plaque Psoriasis) : Addendum zum Auftrag A17-07